Sharecast
{{ menus.user.data_crypt.email }}
{{item.text}}
sharecast
{{ storiesRelated.title }}
{{ value.headline }}
Sector
Pharma and Biotech
Indices
FTSE 100
FTSE-350
FTSE All-Share
Hikma Pharmaceuticals (HIK)
1,854.00p
16:40 25/04/24
2.26%
41.00p
Today's Low & High
1,750.00
/
1,882.00
Open / Previous Close
1,750.00 / 1,854.00
52-week range
1.84%
33.50p
Volume
631,999
Market Cap(million)
£4,113.75m
Advertising
Summary
KEY FINANCIALS
Income & Efficiency
Valuation
Growth
Latest
Forecast
Div Yield
3.1%
n/a
Div Cover
3.1
n/a
Op Mrgn
12.8%
n/a
ROCE
15.8%
Latest
Forecast
P/E
10.4
n/a
PEG
0.4
n/a
Price / Revenue
1.8
n/a
Price / Book value
2.3
Latest
Forecast
Revenue
14.2%
5.3%
PBT
20.6%
n/a
EPS
23.2%
-34.3%
DPS
28.6%
-24.6%
KEY FUNDAMENTALS
Year Ending
Revenue
($m)
Pre-tax
($m)
EPS
P/E
PEG
EPS Growth
Div
Yield
2019-12-31
2,207.00
491.00
$1.50
17.6
1.9
9%
$0.44
1.7%
2020-12-31
2,341.00
558.00
$1.73
19.9
1.3
15%
$0.50
1.5%
2021-12-31
2,553.00
544.00
$1.95
15.4
1.2
13%
$0.54
1.8%
2022-12-31
2,517.00
233.00
$1.81
10.4
-1.5
-7%
$0.56
3.0%
2023-12-31
2,875.00
281.00
$2.23
10.2
0.4
23%
$0.72
3.2%
Latest Webfg News
London close: Stocks finish mixed as US GDP growth slows
Sharecast News
25 Apr
Hikma delivers strong Q1, holds on to guidance
Sharecast News
25 Apr
London close: Stocks rise as BoE keeps rates on hold
Sharecast News
21 Mar
More Webfg News
Regulatory News
Result of AGM
25-Apr-24 14:28
Trading Statement
25-Apr-24 07:01
Director/PDMR Shareholding
17-Apr-24 10:42
Hikma appoints new President of Generics business
15-Apr-24 20:44
Director/PDMR Shareholding
11-Apr-24 22:40
read more news